-+ 0.00%
-+ 0.00%
-+ 0.00%
Lytix Biopharma Considers Private Placement, Retail Offer
Share
Listen to the news
11:40 AM EST, 11/17/2026 (MT Newswires) -- Lytix Biopharma (LYTIX.OL) is considering a private placement of new shares and a separate retail offer to fund clinical trial preparations and working capital, according to a Tuesday release. The clinical-stage biotechnology company aims to raise 60 million Norwegian kroner to 80 million kroner through the private placement, with applications closing Wednesday. DNB Carnegie will manage the offering, which has a minimum order size of 100,000 euros in kroner equivalent. Meanwhile, the retail offer, facilitated by Nordnet Bank, aims to raise up to 1 million euros in kroner equivalent. Both offerings are priced at 8 kroner per share.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending